Clearmind Medicine Inc.
Clearmind Medicine Inc. (CMND) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CMND · as of Jun 8, 2026
Key Statistics
Explore Clearmind Medicine Inc. Data
cmnd stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
cmnd competitorsCMND
CANF
CLDI
CNSP
GRI
JAGXStock Performance
Full HistoryAbout Clearmind Medicine Inc.
Clearmind Medicine Inc. a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including …
what is clearmind medicine inc. · cmnd stock overview · clearmind medicine inc. company profile · who is clearmind medicine inc. ceo · cmnd NASDAQ · clearmind medicine inc. headquarters · clearmind medicine inc. business segments
About Stock Overview & Key Data
Clearmind Medicine Inc. (CMND) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 15, 2022. As of the latest trading session, CMND stock price is $3.64, with a market capitalization of $3.8M. The stock has returned -99.02% over the past 12 months and -79.34% year-to-date.
In fiscal year 2025, Clearmind Medicine Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Clearmind Medicine Inc. (CMND) stock price is $3.64. The stock is traded on NASDAQ under the ticker symbol CMND. The 52-week range is $2.10 – $524.00.